Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Master Agreement (MA)

It is a long and boring agreement to read. The exhibits reveal a lot of information. Basically here is the breakdown for those not familiar with this agreement signed in June 2005 which can be found on the PTSC website under Investor/ SEC filings. Look for an 8K filing in June (125 Pages) for that date:

TPL, Moore and PTSC enter into MA

All settle litigation (Exhibit A)

TPL & PTSC enter into operating agreement (exhibit B)

TPL, PTSC & P Newco enter into commercialization agreement (Exhibit D)

TPL, PTSC enter into the Warrant (Exhibit I), the Registration Rights Agreement (Exhibit J) and the Escrow Agreement (Exhibit E)

Patriot and Intel License (Exhibit H)

Patriot forms wholly owned subsidiary P-Newco and TPL forms wholly owned subsideary T-Newco (Exhibit C)

Patriot, TPL, P-Newco, T-Newco merge with P-Newco as surviving entity (Exhibit G)

TPL and PTSC each contribute $1 million to be paid to PTSC rights holders (Swartz, Caplan, etc.) in exchange for consent and release

Governing law: State of California

Corrections welcome

Share
New Message
Please login to post a reply